Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | TCF7L1 |
Upstream (Parents) |
---|
(<<) CMTM7 → TCF7L1 |
(<<) DUSP4 → TCF7L1 |
(<<) DUSP6 → TCF7L1 |
(<<) FZD4 → TCF7L1 |
(<<) HGS → TCF7L1 |
(<<) KLHL7 → TCF7L1 |
(<<) NEDD4 → TCF7L1 |
(<<) PHGDH → TCF7L1 |
(<<) PLK1 → TCF7L1 |
(<<) SERPINB5 → TCF7L1 |
(<<) SPDEF → TCF7L1 |
(<<) TMEM45B → TCF7L1 |
(<<) TRIB3 → TCF7L1 |
(<<) UGDH → TCF7L1 |
(<<) WWTR1 → TCF7L1 |
Downstream (Children) |
---|
TCF7L1 → ADCY3 (>>) |
TCF7L1 → ALOX15B (>>) |
TCF7L1 → AQP3 (>>) |
TCF7L1 → BAALC (>>) |
TCF7L1 → CDC42EP1 (>>) |
TCF7L1 → CEBPB (>>) |
TCF7L1 → CHODL (>>) |
TCF7L1 → CITED4 (>>) |
TCF7L1 → COTL1 (>>) |
TCF7L1 → DUSP10 (>>) |
TCF7L1 → ELF5 (>>) |
TCF7L1 → ERBB2 (>>) |
TCF7L1 → FAM110C (>>) |
TCF7L1 → FGFR2 (>>) |
TCF7L1 → FZD7 (>>) |
TCF7L1 → GDF15 (>>) |
TCF7L1 → GPRIN2 (>>) |
TCF7L1 → GSTM3 (>>) |
TCF7L1 → ITGB8 (>>) |
TCF7L1 → KHDRBS3 (>>) |
TCF7L1 → KYNU (>>) |
TCF7L1 → MAPK7 (>>) |
TCF7L1 → MLPH (>>) |
TCF7L1 → MPHOSPH6 (>>) |
TCF7L1 → MRAS (>>) |
TCF7L1 → MYC (>>) |
TCF7L1 → NFATC1 (>>) |
TCF7L1 → NFIB (>>) |
TCF7L1 → NFIL3 (>>) |
TCF7L1 → NFIX (>>) |
TCF7L1 → NPAS3 (>>) |
TCF7L1 → PDIA4 (>>) |
TCF7L1 → PKIB (>>) |
TCF7L1 → PLEKHF1 (>>) |
TCF7L1 → PPP1R3D (>>) |
TCF7L1 → PPRC1 (>>) |
TCF7L1 → PTPLA (>>) |
TCF7L1 → ROR1 (>>) |
TCF7L1 → RPS6KB1 (>>) |
TCF7L1 → S100P (>>) |
TCF7L1 → SLC16A6 (>>) |
TCF7L1 → TMEM154 (>>) |
TCF7L1 → TMEM39B (>>) |
TCF7L1 → TMEM87B (>>) |
TCF7L1 → UBE2E3 (>>) |
TCF7L1 → VTCN1 (>>) |